Perceptive Advisors’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.5M | Sell |
|
|||||
|
2025
Q1 | $53.3M | Hold |
|
|||||
|
2024
Q4 | $46.3M | Hold |
|
|||||
|
2024
Q3 | $50M | Hold |
|
|||||
|
2024
Q2 | $30.7M | Buy |
|
|||||
|
2024
Q1 | $28.1M | Hold |
|
|||||
|
2023
Q4 | $30.2M | Sell |
|
|||||
|
2023
Q3 | $75.8M | Hold |
|
|||||
|
2023
Q2 | $95.2M | Hold |
|
|||||
|
2023
Q1 | $113M | Hold |
|
|||||
|
2022
Q4 | $79M | Hold |
|
|||||
|
2022
Q3 | $60.6M | Buy |
|
|||||
|
2022
Q2 | $39.5M | Hold |
|
|||||
|
2022
Q1 | $44M | Hold |
|
|||||
|
2021
Q4 | $39.6M | Hold |
|
|||||
|
2021
Q3 | $87M | Hold |
|
|||||
|
2021
Q2 | $112M | Buy |
|
|||||
|
2021
Q1 | $103M | Buy |
|
|||||
|
2020
Q4 | $43.1M | Hold |
|
|||||
|
2020
Q3 | $46.6M | Buy |
|
|||||
|
2020
Q2 | $12.9M | Hold |
|
|||||
|
2020
Q1 | $7.62M | Hold |
|
|||||
|
2019
Q4 | $17.9M | Hold |
|
|||||
|
2019
Q3 | $16.3M | Hold |
|
|||||
|
2019
Q2 | $18.5M | Hold |
|
|||||
|
2019
Q1 | $27.9M | Hold |
|
|||||
|
2018
Q4 | $24.7M | Hold |
|
|||||
|
2018
Q3 | $42.6M | Hold |
|
|||||
|
2018
Q2 | $24.5M | Hold |
|
|||||
|
2018
Q1 | $23.1M | Hold |
|
|||||
|
2017
Q4 | $21M | Hold |
|
|||||
|
2017
Q3 | $22.2M | Buy |
|
|||||
|
2017
Q2 | $13.4M | Hold |
|
|||||
|
2017
Q1 | $12.9M | Buy |
|
|||||
|
2016
Q4 | $10.4M | Hold |
|
|||||
|
2016
Q3 | $15.2M | Hold |
|
|||||
|
2016
Q2 | $11M | Buy |
|
|||||
|
2016
Q1 | $5.2M | Hold |
|
|||||
|
2015
Q4 | $8.41M | Buy |
|
|||||
|
2015
Q3 | $5.58M | Buy |
|
|||||
|
2015
Q2 | $6.75M | Buy |
|
|||||
|
2015
Q1 | $3.63M | Buy |
|